NEW YORK (TheStreet) -- CHANGE IN RATINGSAccenture ( ACN - Get Report) was upgraded to Outperform at Wells Fargo. Visibility is improving, and business fundamentals appear to have reached an inflection point. Archer-Daniels Midland ( ADM - Get Report) was downgraded to Market Perform at BMO Capital. Valuation call, based on a $36 price target. Beacon Roofing ( BECN - Get Report) was downgraded from Outperform to Neutral at Robert Baird. $16 price target. Shingle pricing has turned negative. ConocoPhillips ( COP - Get Report) was downgraded to Underweight at Morgan Stanley. Valuation call, based on a $56 price target. Deere ( DE - Get Report) was downgraded to Market Perform at Wells Fargo. Company is not likely to raise guidance above current consensus expectations. Amdocs ( DOX - Get Report) was started with a Hold rating at ThinkEquity. $30 price target. Future growth will most likely be driven by acquisitions. Idacorp ( IDA - Get Report) was upgraded from Hold to Buy at Keybanc. $38.50 price target. Two tax deductions will benefit equity value. Limited Brands ( LTD) was downgraded to Sell at Goldman Sachs. $24 price target. Company faces earnings headwinds in 2011. Norfolk Southern ( NSC) was downgraded to Market Perform at Wells Fargo. Valuation call, as coal demand could wane. Rubicon Technology ( RBCN) was initiated with a Sell rating at Merriman, Curhan Ford. Supply has caught up to demand in LCD lighting. The Hanover Insurance Group ( THG) was downgraded to Equal Weight from Overweight at Barclays. Less earnings power and reduced ROE improvement, Barclays said. Price target cut to $46 from $49. Walgreen ( WAG) was upgraded from Equal-Weight to Overweight at Morgan Stanley. $40 price target. Company faces easy comparisons for the flu season. Wright Medical ( WMGI) was downgraded from Outperform to Neutral at Robert Baird. $17 price target. Company could struggle to achieve consensus earnings expectations. Xilinx ( XLNX) was downgraded from Neutral to Sell at Goldman Sachs. Estimates were also cut, as cyclical pressures could hurt earnings. $22 price target.
EMC ( EMC) price target raised at Barclays. EMC shares now seen reaching $28, up from $26, as pure-play storage vendors are positioned well for growth, Barclays said. Maintain Overweight rating. Goldman Sachs ( GS) target, estimates cut at Credit Suisse. Price target trimmed to $190 from $200. Expecting weak third-quarter results and Basel/capital to be a focus, Credit Suisse said. 2010 EPS estimate reduced to $14.4, 2011 set at $19.00. Reiterate Outperform rating. H&R Block ( HRB) target lowered at Goldman. Shares now seen reaching $13, according to Goldman Sachs. Company faces increased mortgage risk. Neutral rating and $13 price target. Incyte ( INCY) target increased to $22 at Oppenheimer. Expect Response trial to be successful. Outperform rating. Intuit ( INTU) target raised at Morgan Stanley. Shares now seen reaching $51, according to Morgan Stanley. Small business demand is growing. Overweight rating. Lockheed Martin ( LMT) numbers lowered at UBS. Shares of LMT now seen reaching $71. Estimates also cut, as the company now sees flat sales in 2011. Neutral rating. Morgan Stanley ( MS) target, estimates lowered at Credit Suisse. Price target reduced to $35 from $37. Expect modestly profitable third-quarter but oversized BV growth, Credit Suisse said. 2010 and 2011 EPS estimates lowered to $2.56 and $3.00, respectively. Maintain Outperform rating. Noble ( NE) estimates lowered through 2011 at Citigroup. New ship was delayed and the company is facing a higher tax rate this quarter. Buy rating and $36 price target. Netflix ( NFLX) shares now seen reaching $180, according to Piper Jaffray. Company continues to have multiple growth drivers. Overweight rating. NetApp ( NTAP) price target boosted to $56 from $40 at Barclays on leading product portfolio that includes NetApp's unified storage architecture. Reiterate Equal Weight rating. Principal Financial ( PFG) estimates cut through 2011 at UBS. Company is leaving the medical insurance business. Neutral rating and $27 price target. PPL ( PPL) estimates, target reduced at Morgan Stanley. Shares now seen reaching $31.50, according to Morgan Stanley. Estimates also cut, given a lower rate base in PA. Overweight rating.